These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 17681244)

  • 21. Perioperative hyperfractionated high-dose rate brachytherapy for the treatment of soft tissue sarcomas: multicentric experience.
    Petera J; Soumarová R; Růzicková J; Neumanová R; Dusek L; Sirák I; Macingová Z; Paluska P; Kasaová L; Hodek M; Vosmik M
    Ann Surg Oncol; 2010 Jan; 17(1):206-10. PubMed ID: 19711130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant high-dose-rate and low-dose-rate brachytherapy with external beam radiation in soft tissue sarcoma: a comparison of outcomes.
    Pohar S; Haq R; Liu L; Koniarczyk M; Hahn S; Damron T; Aronowitz JN
    Brachytherapy; 2007; 6(1):53-7. PubMed ID: 17284387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis.
    Takácsi-Nagy Z; Oberna F; Polgár C; Somogyi A; Major T; Németh G
    Neoplasma; 2001; 48(1):76-81. PubMed ID: 11327543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy.
    Ortholan C; Ramaioli A; Peiffert D; Lusinchi A; Romestaing P; Chauveinc L; Touboul E; Peignaux K; Bruna A; de La Roche G; Lagrange JL; Alzieu C; Gerard JP
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):479-85. PubMed ID: 15890590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer in the oropharynx: cost calculation of different treatment modalities for controlled primaries, relapses and grade III/IV complications.
    Nijdam W; Levendag P; Noever I; Groot CU; Agthoven Mv
    Radiother Oncol; 2005 Oct; 77(1):65-72. PubMed ID: 16213619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definitive radiotherapy for squamous cell carcinoma of the anal canal.
    Rabbani AN; Zlotecki RA; Kirwan J; George TJ; Morris CG; Rout WR; Mendenhall WM
    Am J Clin Oncol; 2010 Feb; 33(1):47-51. PubMed ID: 19704368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer.
    Chapet O; Gerard JP; Riche B; Alessio A; Mornex F; Romestaing P
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1316-24. PubMed ID: 16169674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment outcome with low-dose-rate interstitial brachytherapy in early-stage oral tongue cancers.
    Bhalavat RI; Mahantshetty UM; Tole S; Jamema SV
    J Cancer Res Ther; 2009; 5(3):192-7. PubMed ID: 19841561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: clinical experience with 3 year follow-up.
    Pötter R; Dimopoulos J; Bachtiary B; Sissolak G; Klos B; Rheinthaller A; Kirisits C; Knocke-Abulesz TH
    Radiother Oncol; 2006 Apr; 79(1):80-6. PubMed ID: 16516316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-up.
    Kälkner KM; Wahlgren T; Ryberg M; Cohn-Cedermark G; Castellanos E; Zimmerman R; Nilsson J; Lundell M; Fowler J; Levitt S; Hellström M; Nilsson S
    Acta Oncol; 2007; 46(7):909-17. PubMed ID: 17917823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brachytherapy boost for T1/T2 nasopharyngeal carcinoma.
    Yeo R; Fong KW; Hee SW; Chua ET; Tan T; Wee J
    Head Neck; 2009 Dec; 31(12):1610-8. PubMed ID: 19536853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
    Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
    Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we be more selective and obtain better tissue sparing?
    Levendag P; Nijdam W; Noever I; Schmitz P; van de Pol M; Sipkema D; Braat C; de Boer M; Jansen P
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):713-24. PubMed ID: 15183475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
    Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: results of a phase I to II study.
    Vargas CE; Martinez AA; Boike TP; Spencer W; Goldstein N; Gustafson GS; Krauss DJ; Gonzalez J
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):416-23. PubMed ID: 16879929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma{private}.
    Leung TW; Wong VY; Sze WK; Lui CM; Tung SY
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):361-7. PubMed ID: 17892917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost analysis comparing brachytherapy versus surgery for primary carcinoma of the tonsillar fossa and/or soft palate.
    Nijdam W; Levendag P; Noever I; Uyl-de Groot C; van Agthoven M
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):488-94. PubMed ID: 15145167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.